Clinical Trial Update: Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining exogenous surfactant to prevent bronchopulmonary dysplasia in very preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Infant Prematurity
• Respiratory Distress Syndrome of the Newborn

Drugs mentioned

• Exogenous Surfactant (surfactant)

Snippet

Sponsor: Jean Michel Hascoet | Conditions: Infant, Premature, Diseases, Respiratory Distress Syndrome, Newborn | Phase 4 | Status: COMPLETED